Caesars Entertainment Corp. CZR +26% - The company announced plans to acquire Caesars Acquisition Corp. in a stock-for-stock deal.
Enanta Pharmaceuticals Inc. ENTA +14% - The company announced that the FDA has approved AbbVie’s VIEKIRA PAK, which contains Enanta’s lead protease inhibitor paritaprevir.
Achillion Pharmaceuticals Inc. ACHN +14% - Shares are higher following the company’s announcement of positive drug trial results.
EXACT Sciences Corporation EXAS +7.83% - Late Friday, the company announced an update on CMS reimbursement for Cologuard.
Advaxis Inc. ADXS +7% - Late Friday, the company announced completion of $17M financing.
TASER International Inc. TASR +4% - Oppenheimer analysts initiated coverage on TASER at Outperform.
BioCryst Pharmaceuticals BCRX +4% - The company announced FDA approval of RAPIVAB.
Twitter Inc. TWTR +1.4% - Oppenheimer Initiates coverage on Twitter at Perform with a $36 price target.
Gilead Sciences Inc. GILD -10%- Express Scripts dropped coverage of Gilead’s Hepatitis C drug.
Western Digital Corp WDC -0.8% - Shares were downgraded at Longbow Research to Neutral.
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
